生命科学科技公司10x Genomics（TXG）今日盘中股价大涨13.88%，主要受益于公司发布的强劲财报及乐观前景。
据报道，10x Genomics第三季度营收达1.49亿美元，显著高于分析师预期的1.425亿美元。这一业绩表现展示了公司强劲的业务增长势头。更值得注意的是，公司预计第四季度营收将在1.54亿美元至1.58亿美元之间，同样超出市场普遍预期的1.541亿美元。这一乐观指引进一步提振了投资者对公司未来增长前景的信心。
受此利好消息影响，华尔街分析师纷纷上调对10x Genomics的评级。其中，摩根大通将该公司目标股价从13美元上调至15美元，反映出分析师对公司业绩改善的认可。巴克莱也将目标价从15美元上调至17美元。这些积极的分析师评级调整进一步推动了10x Genomics股价在盘中的大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.